EUVIMEDEUVIMED entdecken
KommentarOpen Access

RWE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 16

Alejandra Castanon, Antonia Tsvetanova, Sreeram V Ramagopalan

Journal of Comparative Effectiveness Research · 2024

DOI: 10.57264/cer-2024-0095 ↗

Kurz gefasst

Kommentar in der Zeitschrift Journal of Comparative Effectiveness Research, 2024. Verfasst von Alejandra Castanon und 2 weiteren Autor:innen. Beteiligte Einrichtung: Lane Clark & Peacock LLP, London, W1U 1DQ, UK. Hauptthemen laut MEDLINE: Technology Assessment, Biomedical. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this update, we discuss recent US FDA guidance offering more specific guidelines on appropriate study design and analysis to support causal inference for non-interventional studies and the launch of the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) public electronic catalogues. We also highlight an article recommending assessing data quality and suitability prior to protocol finalization and a Journal of the American Medical Association -endorsed framework for using causal language when publishing real-world evidence studies. Finally, we explore the potential of large language models to automate the development of health economic models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Technology Assessment, BiomedicalHumansUnited StatesComparative Effectiveness ResearchResearch DesignUnited States Food and Drug AdministrationModels, EconomicReimbursement Mechanisms

Stichwörter der Autor:innen

FDA guidancecausal inferencecausal language frameworkdata quality assessmenthealth technology assessmentlarge language modelsnon-interventional studiespublic electronic cataloguesreal-world datareal-world evidencestudy design

Autor:innen und Institutionen

  • Lane Clark & Peacock LLP, London, W1U 1DQ, UK.
  • Centre for Pharmaceutical Medicine Research, King's College London, London, SE1 9NH, UK.

Zitieren

APA

Castanon, A., Tsvetanova, A., & Ramagopalan, S. V. (2024). RWE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 16. Journal of Comparative Effectiveness Research. https://doi.org/10.57264/cer-2024-0095

Vancouver

Castanon A, Tsvetanova A, Ramagopalan SV. RWE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 16. Journal of Comparative Effectiveness Research. 2024. doi:10.57264/cer-2024-0095

BibTeX
@article{Castanon2024,
  author = {Castanon, Alejandra and Tsvetanova, Antonia and Ramagopalan, Sreeram V},
  title = {RWE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 16},
  journal = {Journal of Comparative Effectiveness Research},
  year = {2024},
  doi = {10.57264/cer-2024-0095}
}
Kostenlos starten →